Pasar al contenido principal

NUEVOS ABORDAJES PARA ESCLARECER LOS MECANISMOS BIOLOGICOS SUBYACENTES A LA PERDIDA DE CONTROL SOBRE LA INGESTA DE COMIDA

PID2020-120029GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POMPEU FABRA CCT

Resultados relacionados

Resultados totales (Incluyendo duplicados): 30
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cannabinoid type-1 receptors in CaMKII neurons drive impulsivity in pathological eating behavior

  • Martín-García, Elena|||0000-0002-4487-3028
  • Domingo-Rodriguez, Laura|||0000-0003-3286-6696
  • Lutz, Beat|||0000-0002-1062-6889
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Ruiz de Azua, Inigo
Overconsumption of palatable food and energy accumulation are evolutionary mechanisms of survival when food is scarce. These innate mechanisms becom detrimental in obesogenic environment promoting obesity and related comorbidities, including mood disorders. This study aims at elucidating the role of the endocannabinoid system in energy accumulation and hedonic feeding. We applied a genetic strategy to reconstitute cannabinoid type-1 receptor (CB1) expression at functional levels specifically in CaMKII+ neurons (CaMKII-CB1-RS) and adipocytes (Ati-CB1-RS), respectively, in a CB1 deficient background. Rescued CB1 expression in CaMKII+ neurons, but not in adipocytes, promotes feeding behavior, leading to fasting-induced hyperphagia, increased motivation, and impulsivity to palatable food seeking. In a diet-induced obesity model, CB1 re-expression in CaMKII+ neurons, but not in adipocytes, compared to complete CB1 deficiency, was sufficient to largely restore weight gain, food intake without any effect on glucose intolerance associated with high-fat diet consumption. In a model of glucocorticoid-mediated metabolic syndrome, CaMKII-CB1-RS mice showed all metabolic alterations linked to the human metabolic syndrome except of glucose intolerance. In a binge-eating model mimicking human pathological feeding, CaMKII-CB1-RS mice showed increased seeking and compulsive behavior to palatable food, suggesting crucial roles in foraging and an enhanced susceptibility to addictive-like eating behaviors. Importantly, other contingent behaviors, including increased cognitive flexibility and reduced anxiety-like behaviors, but not depressive-like behaviors, were also observed. CB1 in CaMKII+ neurons is instrumental in feeding behavior and energy storage under physiological conditions. The exposure to risk factors (hypercaloric diet, glucocorticoid dysregulation) leads to obesity, metabolic syndrome, binge-eating and food addiction.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes

  • Vázquez-Oliver, Anna
  • Pérez-García, Silvia
  • Romero-Pérez, Rafael
  • Pizarro Lozano, Ma. Nieves
  • Galarraga-Shinin, Diana
  • Molina-Porcel, Laura
  • Torre Fornell, Rafael de la
  • Maldonado, Rafael, 1961-
  • Ozaita Mintegui, Andrés, 1969-
INTRODUCTION: Down syndrome (DS) is the most common genetic cause of intellectual disability, affecting cognitive function and increasing the risk of early-onset Alzheimer's disease (AD). The endocannabinoid system may serve as a therapeutic target for cognitive deficits by inhibiting cannabinoid type-1 receptor (CB1R) function. METHODS: CB1R expression was analyzed in the hippocampi of aged DS-associated AD (DSAD) individuals and middle-aged Ts65Dn mice. Long-term oral treatment with the CB1R antagonist rimonabant was used to assess its effects on memory and neuroinflammation in the Ts65Dn mouse model of DS. RESULTS: CB1R expression was significantly increased in both aged DSAD subjects (specifically in the dentate gyrus and CA2 posterior hippocampal subregions) and Ts65Dn mice. Long-term rimonabant treatment improved memory performance, normalized microglial morphology, and reduced plasma inflammatory markers in trisomic mice without preventing neuron decline. DISCUSSION: These findings suggest that sustained CB1R inhibition may enhance cognitive function by modulating neuroinflammation, highlighting its therapeutic potential for cognitive impairments in DS. Highlights: Cannabinoid type-1 receptor (CB1R) expression is increased in the posterior hippocampus of aged Down syndrome (DS) subjects and Ts65Dn mice. Long-term rimonabant treatment enhances memory in middle-aged Ts65Dn mice. CB1R inhibition shifts neuroinflammatory features in Ts65Dn mice. CB1R inhibition does not halt noradrenergic/cholinergic neurodegeneration in Ts65Dn. CB1R inhibition presents potential for memory improvement in DS-related deficits., Ministerio de Ciencia, Innovación y Universidades, Grant/Award Numbers:RTI2018-099282-B-I00, PID2021-123482OB-I00-/MICIN/AEI/10.13039/501100011033/FEDER,PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033; Fondation Jérôme Lejeune, Grant/Award Numbers:1896_GRT-2019B, #2416_GRT-2024B; Bright Focus foundation, Grant/Award Number:CA2018010; Ministerio de Sanidad, Servicios Sociales e Igualdad, Grant/Award Number:RD16/0017/0020; Departament de Recerca i Universitats, Generalitat de Catalunya,Grant/Award Number: 2017SGR-669 Departament d'Economia i Coneixement, Generalitat de Catalunya, Grant/Award Number: 2017SGR-138; Institució Catalana de Recerca i Estudis Avançats, ICREA-Acadèmia2021
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Role of CB2 cannabinoid receptor in the development of food addiction in male mice

  • García Blanco, Alejandra
  • Ramírez López, Ángela, 1992-
  • García-Gutiérrez, María S.
  • Manzanares, Jorge
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
The endocannabinoid system plays an important role in multiple behavioral responses due to its wide distribution in the central nervous system. The cannabinoid CB1 receptor was associated to the loss of behavioral control over food intake occurring during food addiction. The cannabinoid CB2 receptor (CB2R) is expressed in brain areas canonically associated with addictive-like behavior and was linked to drug-addictive properties. In this study, we evaluated for the first time the specific role of the CB2R in food addiction by using a well-validated operant mouse model of long-term training to obtain highly palatable food. We have compared in this model the behavioral responses of wild-type mice, mutant mice constitutively lacking CB2R, and transgenic mice overexpressing CB2R. The lack of CB2R constitutes a protective factor for the development of food addiction and the impulsive and depressive-like behavior associated. In contrast, the overexpression of CB2R induces a vulnerable phenotype toward food addiction after long-term exposure to highly palatable chocolate pellets. Relevant transcriptomic changes were associated to resilience and vulnerability to food addiction depending on the genotype, which provides a mechanistic explanation for these behavioral changes. Therefore, CB2R may constitute a potential therapeutic target for the loss of eating control and the comorbid emotional effects associated to food addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to RM; the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to RM; the “ICREA-Acadèmia” (2020) to RM; the “European Commission-DG Research” (PainFact, H2020-SC1–2019-2-RTD-848099, QSPain Relief, H2020-SC1–2019-2-RTD-848068) to RM; the Spanish”la Caixa” Foundation under the project code LCF/PR/HR22/52420017 to R.M., the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM; the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to RM; PNSD- 2019I006, to EMG; Ministerio de Ciencia e Innovación (ERA-NET) PCI2021–122073-2A to EMG; and “Instituto de Salud Carlos III”, Spanish “Ministerio de Ciencia e Innovación” (RD21/0009/0008, “Red de Investigación en Atención Primaria de Adicciones”) to JM.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Dysregulated eating behaviour and microbiota-based interventions targeting eating disorders and food addiction

  • Samulenaite, Solveiga
  • Rodriguez Parkitna, Jan
  • Baltriukienė, Daiva
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Burokas, Aurelijus, 1982-
The consumption of highly processed, hyperpalatable food in Western societies increases the risk of developing obesity and compulsive eating behaviors, which include food addiction (FA) and eating disorders (EDs), such as bulimia nervosa (BN) and binge eating disorder (BED). These behaviors can lead to a range of health consequences, including cardiovascular and metabolic diseases, cognitive impairments, and mental health disorders, among others. Given the evidence suggesting the involvement of the gut microbiota in regulating eating behavior, in recent years, scientists have sought to identify microbiota signatures associated with EDs and FAs. Multiple pro- and prebiotics, as well as other microbiota-based therapeutic interventions, have been suggested as preventive or treatment strategies for FA and EDs. To provide a comprehensive overview, this review is structured into two main sections. The first section describes compulsive eating behaviors, namely, BN, BED, and FA, recognizing their similarities and differences, and highlighting the importance of the proper distinction for the selection of targeted and effective treatment approaches. The second section provides an extensive summary of the recent research years behind the search for microbiota signatures and potential microbiota-based therapeutic interventions for managing EDs and FA in both humans and animal models., This work was supported by the European Commission under the HORIZON Coordination and Support Actions Grant Pan-European Network for Neuroscience Research Infrastructure and Strengthening of Support capacities (PANERIS), Grant Agreement No. 101160180. And the Research Council of Lithuania (LMTLT) and ERA-NET NEURON Joint Transnational Call (S-NEURON-25-1) for the project “EMPATHY: Early Metabolic Programming Affects Hypothalamus Yielding Eating Disorders.” And the Spanish “Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI)” (PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019 and PDI2023-1511680B-C21), the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (#RD12/0028/0023), the “Generalitat de Catalunya, AGAUR” (#2020 SGR-669), “ICRalterations, with microbiota EA-Acadèmia” (#2025) and the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad,” “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2017I068, #PNSD-2019I006, #PNSD-2023I040) to R.M., "la Caixa Health” LCR/PR/HR22/5240017 to R.M. and E.M-G., and Spanish “Ministerio de Ciencia e Innovación” (ERA-NET) PCI2021-122073-2A to E.M-G.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Auricular transcutaneous vagus nerve stimulation acutely modulates brain connectivity in mice.

  • Brambilla Pisoni, Cecilia, 1993-
  • Muñoz-Moreno, Emma
  • Gallego-Amaro, Ianire
  • Maldonado, Rafael, 1961-
  • Ivorra Cano, Antoni, 1974-
  • Soria Rodríguez, Guadalupe
  • Ozaita Mintegui, Andrés, 1969-
Brain electrical stimulation techniques take advantage of the intrinsic plasticity of the nervous system, opening a wide range of therapeutic applications. Vagus nerve stimulation (VNS) is an approved adjuvant for drug-resistant epilepsy and depression. Its non-invasive form, auricular transcutaneous VNS (atVNS), is under investigation for applications, including cognitive improvement. We aimed to study the effects of atVNS on brain connectivity, under conditions that improved memory persistence in CD-1 male mice. Acute atVNS in the cymba conchae of the left ear was performed using a standard stimulation protocol under light isoflurane anesthesia, immediately or 3 h after the training/familiarization phase of the novel object-recognition memory test (NORT). Another cohort of mice was used for bilateral c-Fos analysis after atVNS administration. Spearman correlation of c-Fos density between each pair of the thirty brain regions analyzed allowed obtaining the network of significant functional connections in stimulated and non-stimulated control brains. NORT performance was enhanced when atVNS was delivered just after, but not 3 h after, the familiarization phase of the task. No alterations in c-Fos density were associated with electrostimulation, but a significant effect of atVNS was observed on c-Fos-based functional connectivity. atVNS induced a clear reorganization of the network, increasing the inter-hemisphere connections and the connectivity of locus coeruleus. Our results provide new insights into the effects of atVNS on memory performance and brain connectivity extending our knowledge of the biological mechanisms of bioelectronics in medicine., The project that gave rise to these results received the support of a fellowship from la Caixa Foundation (ID 100010434). The fellowship code is LCF/BQ/IN18/11660012 (CB-P). This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Slodowska-Curie grant agreement No. 713673. This work was supported by the Ministerio de Economía, Innovación y Competitividad (MINECO) (#RTI2018-099282-B-I00 to AO and PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033 to RM); the Instituto de Salud Carlos III (#RD16/0017/0020 to RM and PI18/00893 cofunded by ERDF A way to make Europe to GS); the Generalitat de Catalunya (2017SGR-669 to RM); the ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to AO, AI, and RM; Grant Unidad de Excelencia María de Maeztu, funded by the MINECO (#MDM-2014-0370); and PLAN E (Plan Español para el Estímulo de la Economía y el Empleo). FEDER funding is also acknowledged.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gut microbial modulation of 3-hydroxyanthranilic acid and dopaminergic signalling influences attention in obesity

  • Castells-Nobau, Anna
  • Samulenaite, Solveiga
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Mayneris Perxachs, Jordi
Background Obesity-related alterations in the gut microbiota have been linked to cognitive decline, yet their relationship with attention remains poorly understood. Objective To evaluate the possible relationships among gut metagenomics, plasma metabolomics and attention. Design We conducted faecal shotgun metagenomics and targeted plasma tryptophan metabolomics across three independent cohorts (n=156, n=124, n=804) with functional validations in preclinical models, including three faecal microbiota transplantation (FMT) experiments in mice and Drosophila melanogaster. Results Obesity was consistently associated with reduced attention. Metagenomics analyses identified Proteobacteria species and microbial functions related to tryptophan biosynthesis from anthranilic acid (AA) as negatively associated with attention in obesity. Plasma tryptophan metabolic profiling and machine learning revealed that 3-hydroxyanthranilic acid (3-HAA) was positively associated with attention, particularly in obesity, while AA showed a negative association. Bariatric surgery improved attention and enriched microbial species linked to attention. In mice, diet-induced obesity (DIO) and microbiota depletion reduced 3-HAA and 5-hydroxy-indole acetic acid (5-HIAA) concentrations in the prefrontal cortex (PFC), which were restored by FMT. Global metabolic profiling (>600 metabolites) of PFC from the FMT group identified 3-HAA and the tryptophan and tyrosine pathways among the most significant in mice receiving microbiota from high-attention donors. A second FMT experiment also revealed a consistent enrichment of the tryptophan and tyrosine metabolism at the transcriptional level in the PFC, with Haao (3-hydroxyantrhanilic acid dioxygenase) and Aox4 (aldehyde oxidase 4), key in 3-HAA and 5-HIAA degradation, among the significantly regulated genes. In a third FMT study, attentional traits were transmitted from humans to mice alongside modulation of serotonergic and dopaminergic pathways. In Drosophila, mono-colonisation with Enterobacter cloacae and DIO induced attention deficit-like behaviours, which were mitigated by 3-HAA supplementation. Conclusions We have identified the microbiota and 3-HAA as potential therapeutic targets to improve attention, especially in obesity., This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund. "A way to make Europe") to JM-P and PI21/01361 and PI24/00185 and ICREA-Acadèmia (#2021) to JMF-R, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P, and Generalitat de Catalunya 2021 SGR 01263. This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCCADGUT to JM-P. AF is funded by the Horizon 2020 Framework Programme of the European Union under the Marie Sklodowska-Curie Innovative Training Network grant agreement No 859890. MA-R is funded by Instituto de Salud Carlos III (Madrid, Spain) through a predoctoral Río Hortega contract CM19/00190 (co-funded by European Regional Development Fund "Investing in your future"). AC-N is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP24/00033 (co-funded by European Regional Development Fund "Investing in your future"). IDIBGI is a CERCA centre from the "CERCA Programme/Generalitat de Catalunya". This study was conducted using samples/data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects (PECT) within the RIS3Cat and the Catalonia ERDF Operational Programme 2014-2020. It was co-financed by the European Regional Development Fund (ERDF) of the European Union under the Catalonia ERDF Operational Programme 2014-2020 and by the Diputació de Girona. We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. This work was also supported by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI) (PID2020- 120029GB-I00/MICIN/AEI/ 10.13039/501100011033, RD21/0009/0019 and PDI20231511680B-C21), the Spanish "Instituto de Salud Carlos III, RETICSRTA" (#RD12/0028/0023), the "Generalitat de Catalunya, AGAUR" (#2017 SGR-669), "ICREA-Acadèmia" (#2015) and the Spanish "Ministerio de Sanidad, Servicios Sociales e Igualdad", "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD-2017I068) to RM, la Caixa Health" LCR/PR/HR22/5240017 to RM and EM-G, "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD2019I006, #PNSD-2023I040) and Spanish "Ministerio de Ciencia e Innovación" (ERA-NET) PCI2021-122073-2A to EM-G.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Microbiota alterations in proline metabolism impact depression

  • Mayneris Perxachs, Jordi
  • Martin, Miquel
  • Burokas, Aurelijus, 1982-
  • Escrichs, Anira
  • Deco, Gustavo
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with low treatment efficacy. However, the field is dominated by underpowered studies focusing on major depression not addressing microbiome functionality, compositional nature, or confounding factors. We applied a multi-omics approach combining pre-clinical models with three human cohorts including patients with mild depression. Microbial functions and metabolites converging onto glutamate/GABA metabolism, particularly proline, were linked to depression. High proline consumption was the dietary factor with the strongest impact on depression. Whole-brain dynamics revealed rich club network disruptions associated with depression and circulating proline. Proline supplementation in mice exacerbated depression along with microbial translocation. Human microbiota transplantation induced an emotionally impaired phenotype in mice and alterations in GABA-, proline-, and extracellular matrix-related prefrontal cortex genes. RNAi-mediated knockdown of proline and GABA transporters in Drosophila and mono-association with L. plantarum, a high GABA producer, conferred protection against depression-like states. Targeting the microbiome and dietary proline may open new windows for efficient depression treatment., This work was partially supported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, and PI21/01361 to J.M.F.-R. and PI20/01090 (co-funded by the European Regional Development Fund. “A way to make Europe”) to J.M.-P.; the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R.; the Spanish Ministry of Science, Innovation and Universities (PID2019-105969GB-I00); Generalitat Valenciana (Prometeo/2018/133), Spain; and Fondo Europeo de Desarrollo Regional (FEDER) funds to A.M. This work was also supported by the European Commission (FP7, NeuroPain #2013-602891); the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020) to R.M.; the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) to R.M.; Ministry of Science and Innovation and State Research Agency (#PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033) to R.M.; the European Regional Development Fund (project no. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra program (POCTEFA, 2014–2020). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00) and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [SLT002/16/00250]) to R.P. M.A.-R. is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). J.M.-P. is funded by a Miguel Servet contract (CP18/00009) from the Instituto de Salud Carlos III. J.S. is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. M.J. is a professor under “Serra Hunter” program (Generalitat de Catalunya). The graphical abstract was created with BioRender.com. We would like to thank Martijn Eidhof for his help in building the stress treatment machine for Drosophila.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model

  • Cajiao-Manrique, María Del Mar
  • Casadó-Anguera, Verònica
  • García Blanco, Alejandra
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Background: Cannabis addiction is a chronically relapsing disorder lacking effective treatment. Regular cannabis consumption typically begins during adolescence, and this early cannabinoid exposure may increase the risk for drug addiction in adulthood. Objective: This study investigates the development of cannabis addiction-like behavior in adult mice after adolescent exposure to the main psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC). Methods: Adolescent male mice were exposed to 5 mg/kg of THC from postnatal days 37 to 57. Operant self-administration sessions of WIN 55,212-2 (12.5 μg/kg/infusion) were conducted for 10 days. Mice were tested for three addiction-like criteria (persistence of response, motivation, and compulsivity), two parameters related to craving (resistance to extinction and drug-seeking behavior), and two phenotypic vulnerability traits related to substance use disorders (impulsivity and reward sensitivity). Additionally, qPCR assays were performed to detect differentially expressed genes in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), dorsal striatum, and hippocampus (HPC) of "addicted" and "non-addicted" mice. Results: Adolescent THC exposure did not modify WIN 55,212-2 reinforcement nor the development of cannabis addiction-like behavior. Inversely, THC pre-exposed mice displayed impulsive-like behavior in adulthood, which was more pronounced in mice that developed the addiction-like criteria. Moreover, downregulated drd2 and adora2a gene expression in NAc and HPC was revealed in THC pre-exposed mice, as well as a downregulation of drd2 expression in mPFC of vehicle pre-treated mice that developed addiction-like behaviors. Discussion: These findings suggest that adolescent THC exposure may promote impulsivity-like behavior in adulthood, associated with downregulated drd2 and adora2a expression in NAc and HPC., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, R D21/0009/0019) to RM, the “Generalitat de Catalunya, AGAUR” (2017 SGR-669) to RM, the “ICREA-Acadèmia” (2020) to RM, the “European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099 and QSPain Relief, H2020-SC1-2019-2-RTD-848068) to RM, the Spanish “La Caixa” Foundation under the project code LCF/PR/HR22/52420017 to RM, the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM, the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD-2021I076 to RM and PNSD-2019I006 to EM-G), and Ministerio de Ciencia e Innovación (ERA-NET NEURON) PCI2021-122073-2A to EM-G. MC-M acknowledged the Generalitat de Catalunya and the AGAUR for a “FI-SDUR” scholarship (EMC/3345/2020). AG-B acknowledged the Generalitat de Catalunya and the AGAUR for the “FI” scholarship (FI_B00337_2020). VC-A acknowledged the Spanish MCIN/AEI/10.13039/501100011033 for a “Juan de la Cierva” fellowship (FJC2019-041020-I).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulenaite, Solveiga
  • García Blanco, Alejandra
  • Mayneris Perxachs, Jordi
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Objective: Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction. Design: We used the Yale Food Addiction Scale (YFAS) 2.0 criteria to classify extreme food addiction in mouse and human subpopulations to identify gut microbiota signatures associated with vulnerability to this disorder. Results: Both animal and human cohorts showed important similarities in the gut microbiota signatures linked to food addiction. The signatures suggested possible non-beneficial effects of bacteria belonging to the Proteobacteria phylum and potential protective effects of Actinobacteria against the development of food addiction in both cohorts of humans and mice. A decreased relative abundance of the species Blautia wexlerae was observed in addicted humans and of Blautia genus in addicted mice. Administration of the non-digestible carbohydrates, lactulose and rhamnose, known to favour Blautia growth, led to increased relative abundance of Blautia in mice faeces in parallel with dramatic improvements in food addiction. A similar improvement was revealed after oral administration of Blautia wexlerae as a beneficial microbe. Conclusion: By understanding the crosstalk between this behavioural alteration and gut microbiota, these findings constitute a step forward to future treatments for food addiction and related eating disorders., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish 'Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)' (PID2020- 120029GB-I00/MICIU/AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), 'La Marató de TV3' #20221830, ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to EM-G. Spanish-MINECO (#SAF2017-84060-R-AEI/FEDER-UE) to LD-R, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100, #PID2021-127776OB-I00), ‘AGAUR-Generalitat de Catalunya’ (#2017-SGR-738, #2021-SGR-01093) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT-K-718-03-0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), 'La Marató de TV3' #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB-I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the 'CERCA Programme/Generalitat de Catalunya'.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Contribution of CD4+ cells in the emotional alterations induced by endometriosis in mice

  • Escudero Lara, Alejandra, 1992-
  • Cabañero Ferri, David
  • Maldonado, Rafael, 1961-
Endometriosis is a disease defined by the presence of endometrial tissue in extrauterine locations. This chronic condition is frequently associated with pain and emotional disorders and has been related with altered immune function. However, the specific involvement of immune cells in pain and behavioral symptoms of endometriosis has not been yet elucidated. Here, we implement a mouse model of non-surgical endometriosis in which immunocompetent mice develop abdomino-pelvic hypersensitivity, cognitive deficits, anxiety and depressive-like behaviors. This behavioral phenotype correlates with expression of inflammatory markers in the brain, including the immune cell marker CD4. Depletion of CD4 + cells decreases the anxiety-like behavior of mice subjected to the endometriosis model, whereas abdomino-pelvic hypersensitivity, depressive-like behavior and cognitive deficits remain unaltered. The present data reveal the involvement of the immune response characterized by CD4 + white blood cells in the anxiety-like behavior induced by endometriosis in mice. This model, which recapitulates the symptoms of human endometriosis, may be a useful tool to study the immune mechanisms involved in pain and behavioral alterations associated to endometriosis., “Instituto de Salud Carlos III,” “Redes temáticas de investigación cooperativa en salud—Red de trastornos adictivos” (#RD16/0017/0020), “Ministerio de Ciencia e Innovación” MICIN y “Agencia Estatal de Investigación” AEI (#PID2020-120029GBI00/MICIN/AEI/10.13039/50110001 1033), and “Generalitat de Catalunya- Agència de Gestió d’Ajuts Universitaris i de Recerca-AGAUR” (#2017-SGR-669 and #ICREA Acadèmia2020) to RM are acknowledged.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Cannabinoid type-1 receptors in CaMKII neurons drive impulsivity in pathological eating behavior

  • Martín García, Elena, 1975-
  • Domingo Rodriguez, Laura, 1992-
  • Lutz, Beat
  • Maldonado, Rafael, 1961-
  • Ruiz de Azua, Iñigo
Objectives: Overconsumption of palatable food and energy accumulation are evolutionary mechanisms of survival when food is scarce. These innate mechanisms becom detrimental in obesogenic environment promoting obesity and related comorbidities, including mood disorders. This study aims at elucidating the role of the endocannabinoid system in energy accumulation and hedonic feeding. Methods: We applied a genetic strategy to reconstitute cannabinoid type-1 receptor (CB1) expression at functional levels specifically in CaMKII+ neurons (CaMKII-CB1-RS) and adipocytes (Ati-CB1-RS), respectively, in a CB1 deficient background. Results: Rescued CB1 expression in CaMKII+ neurons, but not in adipocytes, promotes feeding behavior, leading to fasting-induced hyperphagia, increased motivation, and impulsivity to palatable food seeking. In a diet-induced obesity model, CB1 re-expression in CaMKII+ neurons, but not in adipocytes, compared to complete CB1 deficiency, was sufficient to largely restore weight gain, food intake without any effect on glucose intolerance associated with high-fat diet consumption. In a model of glucocorticoid-mediated metabolic syndrome, CaMKII-CB1-RS mice showed all metabolic alterations linked to the human metabolic syndrome except of glucose intolerance. In a binge-eating model mimicking human pathological feeding, CaMKII-CB1-RS mice showed increased seeking and compulsive behavior to palatable food, suggesting crucial roles in foraging and an enhanced susceptibility to addictive-like eating behaviors. Importantly, other contingent behaviors, including increased cognitive flexibility and reduced anxiety-like behaviors, but not depressive-like behaviors, were also observed. Conclusions: CB1 in CaMKII+ neurons is instrumental in feeding behavior and energy storage under physiological conditions. The exposure to risk factors (hypercaloric diet, glucocorticoid dysregulation) leads to obesity, metabolic syndrome, binge-eating and food addiction., This work was supported by CRC1193 “Neurobiology of resilience” to B.L.; EU-FP7 REPROBESITY (HEALTHF2- 2008-223713 to B.L.); Spanish “Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI)” (PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019 and PDI2023-1511680B-C21), the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (#RD12/0028/0023), the “Generalitat de Catalunya, AGAUR” (#2017 SGR-669), “ICREA-Acadèmia” (#2015) and the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad”, “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2017I068) to R.M., "la Caixa Health" LCR/PR/HR22/5240017 to R.M. and E.M-G., “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2019I006, #PNSD-2023I040) and Spanish “Ministerio de Ciencia e Innovación” (ERA-NET) PCI2021-122073-2A to E.M-G.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients

  • Grau, Santiago
  • Vela, José Miguel
  • Gurt, Alba
  • Barceló Vidal, Jaime
  • Ojeda, Fabiola
  • López, Iago
  • Gómez García, Laura
  • Loza García, María Isabel
  • Martín García, Elena
  • Maldonado, Rafael
  • Monfort, Jordi
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Microviridae bacteriophages influence behavioural hallmarks of food addiction via tryptophan and tyrosine signalling pathways

  • Castells-Nobau, Anna
  • Puig, Irene
  • Motger-Albertí, Anna
  • Vega-Correa, Lisset de la
  • Rosell-Díaz, Marisel
  • Arnoriaga-Rodríguez, María
  • Escrichs, Anira
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Ramió-Torrentà, Lluís
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Pamplona, Reinald
  • Jové, Mariona
  • Sol, Joaquim
  • Martin-Garcia, Elena
  • Martinez-Garcia, Manuel
  • Deco, Gustavo
  • Maldonado-Lopez, Rafael
  • Fernández-Real, José-Manuel
  • Mayneris-Perxachs, Jordi
  • Martinez-Garcia, Manuel|||/items/8fc0773c-5327-46a0-9cda-e5d2ac19bc69
Food addiction contributes to the obesity pandemic, but the connection between how the gut microbiome is linked to food addiction remains largely unclear. Here we show that Microviridae bacteriophages, particularly Gokushovirus WZ-2015a, are associated with food addiction and obesity across multiple human cohorts. Further analyses reveal that food addiction and Gokushovirus are linked to serotonin and dopamine metabolism. Mice receiving faecal microbiota and viral transplantation from human donors with the highest Gokushovirus load exhibit increased food addiction along with changes in tryptophan, serotonin and dopamine metabolism in different regions of the brain, together with alterations in dopamine receptors. Mechanistically, targeted tryptophan analysis shows lower anthranilic acid (AA) concentrations associated with Gokushovirus. AA supplementation in mice decreases food addiction and alters pathways related to the cycle of neurotransmitter synthesis release. In Drosophila, AA regulates feeding behaviour and addiction-like ethanol preference. In summary, this study proposes that bacteriophages in the gut microbiome contribute to regulating food addiction by modulating tryptophan and tyrosine metabolism.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microbiota alterations in proline metabolism impact depression

  • Mayneris-Perxachs, Jordi
  • Castells-Nobau, Anna
  • Arnoriaga-Rodríguez, María
  • Martin, Miquel
  • Vega-Correa, Lisset de la
  • Zapata-Tona, Cristina
  • Burokas, Aurelijus
  • Blasco, Gerard
  • Coll, Clàudia
  • Escrichs, Anira
  • Biarnés, Carles
  • Moreno-Navarrete, José Maria
  • Puig, Josep
  • Garre-Olmo, Josep
  • Ramos, Rafel
  • Pedraza, Salvador
  • Brugada, Ramon
  • Vilanova, Joan C.
  • Serena, Joaquín
  • Gich, Jordi
  • Ramió-Torrentà, Lluís
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Pamplona, Reinald
  • Sol, Joaquim
  • Jové, Mariona
  • Ricart, Wifredo
  • Portero-Otín, Manuel
  • Deco, Gustavo
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with low treatment efficacy. However, the field is dominated by underpowered studies focusing on major depression not addressing microbiome functionality, compositional nature, or confounding factors. We applied a multi-omics approach combining pre-clinical models with three human cohorts including patients with mild depression. Microbial functions and metabolites converging onto glutamate/GABA metabolism, particularly proline, were linked to depression. High proline consumption was the dietary factor with the strongest impact on depression. Whole-brain dynamics revealed rich club network disruptions associated with depression and circulating proline. Proline supplementation in mice exacerbated depression along with microbial translocation. Human microbiota transplantation induced an emotionally impaired phenotype in mice and alterations in GABA-, proline-, and extracellular matrix-related prefrontal cortex genes. RNAi-mediated knockdown of proline and GABA transporters in Drosophila and mono-association with L. plantarum, a high GABA producer, conferred protection against depression-like states. Targeting the microbiome and dietary proline may open new windows for efficient depression treatment., This work was partially supported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, and PI21/01361 to J.M.F.-R. and PI20/01090 (co-funded by the European Regional Development Fund. “A way to make Europe”) to J.M.-P.; the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R.; the Spanish Ministry of Science, Innovation and Universities (PID2019-105969GB-I00); Generalitat Valenciana (Prometeo/2018/133), Spain; and Fondo Europeo de Desarrollo Regional (FEDER) funds to A.M. This work was also supported by the European Commission (FP7, NeuroPain #2013-602891); the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020) to R.M.; the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) to R.M.; Ministry of Science and Innovation and State Research Agency (#PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033) to R.M.; the European Regional Development Fund (project no. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra program (POCTEFA, 2014–2020). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00) and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [SLT002/16/00250]) to R.P. M.A.-R. is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). J.M.-P. is funded by a Miguel Servet contract (CP18/00009) from the Instituto de Salud Carlos III. J.S. is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. M.J. is a professor under “Serra Hunter” program (Generalitat de Catalunya)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris-Perxachs, Jordi
  • Arnoriaga-Rodríguez, María
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Clàudia
  • Zapata-Tona, Cristina
  • Pedraza, Salvador
  • Pérez-Brocal, Vicente
  • Ramió-Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové, Mariona
  • Sol, Joaquim
  • Portero-Otín, Manuel
  • Pamplona, Reinald
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of CB2 cannabinoid receptor in the development of food addiction in male mice

  • García-Blanco, Alejandra
  • Ramírez-López, Á.
  • Navarrete, Francisco
  • García-Gutiérrez, María Salud
  • Manzanares, Jorge
  • Martín-García, Elena
  • Maldonado, Rafael
The endocannabinoid system plays an important role in multiple behavioral responses due to its wide distribution in the central nervous system. The cannabinoid CB1 receptor was associated to the loss of behavioral control over food intake occurring during food addiction. The cannabinoid CB2 receptor (CB2R) is expressed in brain areas canonically associated with addictive-like behavior and was linked to drug-addictive properties. In this study, we evaluated for the first time the specific role of the CB2R in food addiction by using a well-validated operant mouse model of long-term training to obtain highly palatable food. We have compared in this model the behavioral responses of wild-type mice, mutant mice constitutively lacking CB2R, and transgenic mice overexpressing CB2R. The lack of CB2R constitutes a protective factor for the development of food addiction and the impulsive and depressive-like behavior associated. In contrast, the overexpression of CB2R induces a vulnerable phenotype toward food addiction after long-term exposure to highly palatable chocolate pellets. Relevant transcriptomic changes were associated to resilience and vulnerability to food addiction depending on the genotype, which provides a mechanistic explanation for these behavioral changes. Therefore, CB2R may constitute a potential therapeutic target for the loss of eating control and the comorbid emotional effects associated to food addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to RM; the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to RM; the “ICREA-Acadèmia” (2020) to RM; the “European Commission-DG Research” (PainFact, H2020-SC1–2019-2-RTD-848099, QSPain Relief, H2020-SC1–2019-2-RTD-848068) to RM; the Spanish”la Caixa” Foundation under the project code LCF/PR/HR22/52420017 to R.M., the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM; the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to RM; PNSD- 2019I006, to EMG; Ministerio de Ciencia e Innovación (ERA-NET) PCI2021–122073-2A to EMG; and “Instituto de Salud Carlos III”, Spanish “Ministerio de Ciencia e Innovación” (RD21/0009/0008, “Red de Investigación en Atención Primaria de Adicciones”) to JM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulėnaitė, Solveiga
  • García-Blanco, Alejandra
  • Mayneris-Perxachs, Jordi
  • Domingo-Rodríguez, Laura
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus
  • Espinosa-Carrasco, Jose
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández-Real, Jose Manuel
  • Maldonado, Rafael
  • Martín-García, Elena
Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish ’Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)’ (PID2020- 120029GB-I00/ MICIU/ AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ’Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ’Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), ’La Marató de TV3’ #20221830, ’ICREA-Acadèmia’ (#2015) and the Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073- 2A to EM-G. Spanish-MINECO (#SAF2017-84060- R- AEI/ FEDER-UE) to LD-R, Spanish ’Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968- B- 100, #PID2021-127776OB- I00), ’AGAUR-Generalitat de Catalunya’ (#2017-SGR- 738, #2021-SGR- 01093) and Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT- K- 718- 03- 0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), ’La Marató de TV3’ #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB- I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the ’CERCA Programme/Generalitat de Catalunya’., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microviridae bacteriophages influence behavioural hallmarks of food addiction via tryptophan and tyrosine signalling pathways

  • Castells-Nobau, Anna
  • Puig, Irene
  • Motger-Albertí, Anna
  • Vega-Correa, Lisset de la
  • Rosell-Díaz, Marisel
  • Arnoriaga-Rodríguez, María
  • Escrichs, Anira
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Ramió-Torrentà, Lluís
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Pamplona, Reinald
  • Jové, Mariona
  • Sol, Joaquim
  • Martin-Garcia, Elena
  • Martínez-García, Manuel
  • Deco, Gustavo
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
  • Mayneris-Perxachs, Jordi
The raw metagenomics sequence data derived from human samples in the IRONMET-CGM, IRONMET, Aging Imageomics and Health Imageomics cohorts have been deposited in the European Nucleotide Archive under project numbers PRJEB58106, PRJEB39631, PRJEB52682 and PRJEB61680, respectively. The raw metagenomics sequence data from the second FMT experiment have also been deposited in the European Nucleotide Archive under project number PRJEB39631., Food addiction contributes to the obesity pandemic, but the connection between how the gut microbiome is linked to food addiction remains largely unclear. Here we show that Microviridae bacteriophages, particularly Gokushovirus WZ-2015a, are associated with food addiction and obesity across multiple human cohorts. Further analyses reveal that food addiction and Gokushovirus are linked to serotonin and dopamine metabolism. Mice receiving faecal microbiota and viral transplantation from human donors with the highest Gokushovirus load exhibit increased food addiction along with changes in tryptophan, serotonin and dopamine metabolism in different regions of the brain, together with alterations in dopamine receptors. Mechanistically, targeted tryptophan analysis shows lower anthranilic acid (AA) concentrations associated with Gokushovirus. AA supplementation in mice decreases food addiction and alters pathways related to the cycle of neurotransmitter synthesis release. In Drosophila, AA regulates feeding behaviour and addiction-like ethanol preference. In summary, this study proposes that bacteriophages in the gut microbiome contribute to regulating food addiction by modulating tryptophan and tyrosine metabolism., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the project PI15/01934 to J.M.F.-R. and the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) ‘A way to make Europe’) to J.M.-P. (HR22-00737). The Aging Imageomics Study was funded by Pla estratègic de recerca i innovació en salut 2016–2020 from Generalitat de Catalunya (reference no. SLT002/16/00250). Health Imageomics was funded by Health LivingLab operation of the Girona Healthy Region Program, which was granted by the Projectes d’Especialització i Competitivitat Territorial of the RIS3Cat and the Operative Programme of the European Regional Development Fund of Catalonia 2014–2020. This work was also supported by the Spanish ‘Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación’ (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to R.M.; the ‘Generalitat de Catalunya, AGAUR’ (2017 SGR-669, to R.M.; the ‘ICREA-Acadèmia’ (2020, to R.M.); the ‘European Commission-DG Research’ (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068, to R.M.); the Spanish ‘la Caixa’ Foundation under project code LCF/PR/HR22/52420017 to R.M. and J.M.F.-R.; the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (RD16/0017/0020, to R.M.); the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas’ (PNSD-2021I076, to R.M.; PNSD-2023I040, to E.M.G.; and Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to E.M.G. This study has been co-financed by FEDER funds from the European Union (‘A way to build Europe’) and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to R.P. IDIBGI is a CERCA Programme/Generalitat de Catalunya. J.M.-P. and A.C.N. are funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 and Sara Borrell Program CD20/00051 (co-funded by the European Union under the European Social Fund ‘Investing in Your Future’), respectively. L.V.-C. is funded by the Program for the Promotion of Talent and Employability (Generalitat de Catalunya) SLT017_20_000164. This study was conducted using samples and/or data from the Aging Imageomics Study, supported by the Generalitat de Catalunya through the Strategic Plan for Health Research and Innovation 2016–2020 (SLT002/16/00250). We particularly acknowledge the participants of the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. This study was conducted using samples and/or data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects within the RIS3Cat and the Catalonia European Regional Development Fund (ERDF) Operational Programme 2014–2020. It was co-financed by the ERDF of the European Union under the Catalonia ERDF Operational Programme 2014–2020 and by the Diputació de Girona. Illustrations were created with Biorender.com., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cannabinoid type-1 receptors in CaMKII neurons drive impulsivity in pathological eating behavior

  • Martín García, Elena, 1975-
  • Domingo Rodriguez, Laura, 1992-
  • Lutz, Beat
  • Maldonado, Rafael, 1961-
  • Ruiz de Azua, Iñigo
Objectives: Overconsumption of palatable food and energy accumulation are evolutionary mechanisms of survival when food is scarce. These innate mechanisms becom detrimental in obesogenic environment promoting obesity and related comorbidities, including mood disorders. This study aims at elucidating the role of the endocannabinoid system in energy accumulation and hedonic feeding. Methods: We applied a genetic strategy to reconstitute cannabinoid type-1 receptor (CB1) expression at functional levels specifically in CaMKII+ neurons (CaMKII-CB1-RS) and adipocytes (Ati-CB1-RS), respectively, in a CB1 deficient background. Results: Rescued CB1 expression in CaMKII+ neurons, but not in adipocytes, promotes feeding behavior, leading to fasting-induced hyperphagia, increased motivation, and impulsivity to palatable food seeking. In a diet-induced obesity model, CB1 re-expression in CaMKII+ neurons, but not in adipocytes, compared to complete CB1 deficiency, was sufficient to largely restore weight gain, food intake without any effect on glucose intolerance associated with high-fat diet consumption. In a model of glucocorticoid-mediated metabolic syndrome, CaMKII-CB1-RS mice showed all metabolic alterations linked to the human metabolic syndrome except of glucose intolerance. In a binge-eating model mimicking human pathological feeding, CaMKII-CB1-RS mice showed increased seeking and compulsive behavior to palatable food, suggesting crucial roles in foraging and an enhanced susceptibility to addictive-like eating behaviors. Importantly, other contingent behaviors, including increased cognitive flexibility and reduced anxiety-like behaviors, but not depressive-like behaviors, were also observed. Conclusions: CB1 in CaMKII+ neurons is instrumental in feeding behavior and energy storage under physiological conditions. The exposure to risk factors (hypercaloric diet, glucocorticoid dysregulation) leads to obesity, metabolic syndrome, binge-eating and food addiction., This work was supported by CRC1193 “Neurobiology of resilience” to B.L.; EU-FP7 REPROBESITY (HEALTHF2- 2008-223713 to B.L.); Spanish “Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI)” (PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019 and PDI2023-1511680B-C21), the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (#RD12/0028/0023), the “Generalitat de Catalunya, AGAUR” (#2017 SGR-669), “ICREA-Acadèmia” (#2015) and the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad”, “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2017I068) to R.M., "la Caixa Health" LCR/PR/HR22/5240017 to R.M. and E.M-G., “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2019I006, #PNSD-2023I040) and Spanish “Ministerio de Ciencia e Innovación” (ERA-NET) PCI2021-122073-2A to E.M-G.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gut microbial modulation of 3-hydroxyanthranilic acid and dopaminergic signalling influences attention in obesity

  • Castells-Nobau, Anna
  • Samulenaite, Solveiga
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Mayneris Perxachs, Jordi
Background Obesity-related alterations in the gut microbiota have been linked to cognitive decline, yet their relationship with attention remains poorly understood. Objective To evaluate the possible relationships among gut metagenomics, plasma metabolomics and attention. Design We conducted faecal shotgun metagenomics and targeted plasma tryptophan metabolomics across three independent cohorts (n=156, n=124, n=804) with functional validations in preclinical models, including three faecal microbiota transplantation (FMT) experiments in mice and Drosophila melanogaster. Results Obesity was consistently associated with reduced attention. Metagenomics analyses identified Proteobacteria species and microbial functions related to tryptophan biosynthesis from anthranilic acid (AA) as negatively associated with attention in obesity. Plasma tryptophan metabolic profiling and machine learning revealed that 3-hydroxyanthranilic acid (3-HAA) was positively associated with attention, particularly in obesity, while AA showed a negative association. Bariatric surgery improved attention and enriched microbial species linked to attention. In mice, diet-induced obesity (DIO) and microbiota depletion reduced 3-HAA and 5-hydroxy-indole acetic acid (5-HIAA) concentrations in the prefrontal cortex (PFC), which were restored by FMT. Global metabolic profiling (>600 metabolites) of PFC from the FMT group identified 3-HAA and the tryptophan and tyrosine pathways among the most significant in mice receiving microbiota from high-attention donors. A second FMT experiment also revealed a consistent enrichment of the tryptophan and tyrosine metabolism at the transcriptional level in the PFC, with Haao (3-hydroxyantrhanilic acid dioxygenase) and Aox4 (aldehyde oxidase 4), key in 3-HAA and 5-HIAA degradation, among the significantly regulated genes. In a third FMT study, attentional traits were transmitted from humans to mice alongside modulation of serotonergic and dopaminergic pathways. In Drosophila, mono-colonisation with Enterobacter cloacae and DIO induced attention deficit-like behaviours, which were mitigated by 3-HAA supplementation. Conclusions We have identified the microbiota and 3-HAA as potential therapeutic targets to improve attention, especially in obesity., This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund. "A way to make Europe") to JM-P and PI21/01361 and PI24/00185 and ICREA-Acadèmia (#2021) to JMF-R, the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P, and Generalitat de Catalunya 2021 SGR 01263. This work has also been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health through the project PPCCADGUT to JM-P. AF is funded by the Horizon 2020 Framework Programme of the European Union under the Marie Sklodowska-Curie Innovative Training Network grant agreement No 859890. MA-R is funded by Instituto de Salud Carlos III (Madrid, Spain) through a predoctoral Río Hortega contract CM19/00190 (co-funded by European Regional Development Fund "Investing in your future"). AC-N is funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP24/00033 (co-funded by European Regional Development Fund "Investing in your future"). IDIBGI is a CERCA centre from the "CERCA Programme/Generalitat de Catalunya". This study was conducted using samples/data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects (PECT) within the RIS3Cat and the Catalonia ERDF Operational Programme 2014-2020. It was co-financed by the European Regional Development Fund (ERDF) of the European Union under the Catalonia ERDF Operational Programme 2014-2020 and by the Diputació de Girona. We want to particularly acknowledge the participants, to the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. This work was also supported by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI) (PID2020- 120029GB-I00/MICIN/AEI/ 10.13039/501100011033, RD21/0009/0019 and PDI20231511680B-C21), the Spanish "Instituto de Salud Carlos III, RETICSRTA" (#RD12/0028/0023), the "Generalitat de Catalunya, AGAUR" (#2017 SGR-669), "ICREA-Acadèmia" (#2015) and the Spanish "Ministerio de Sanidad, Servicios Sociales e Igualdad", "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD-2017I068) to RM, la Caixa Health" LCR/PR/HR22/5240017 to RM and EM-G, "Plan Nacional Sobre Drogas of the Spanish Ministry of Health" (#PNSD2019I006, #PNSD-2023I040) and Spanish "Ministerio de Ciencia e Innovación" (ERA-NET) PCI2021-122073-2A to EM-G.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Role of CB2 cannabinoid receptor in the development of food addiction in male mice

  • García Blanco, Alejandra
  • Ramírez López, Ángela, 1992-
  • García-Gutiérrez, María S.
  • Manzanares, Jorge
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
The endocannabinoid system plays an important role in multiple behavioral responses due to its wide distribution in the central nervous system. The cannabinoid CB1 receptor was associated to the loss of behavioral control over food intake occurring during food addiction. The cannabinoid CB2 receptor (CB2R) is expressed in brain areas canonically associated with addictive-like behavior and was linked to drug-addictive properties. In this study, we evaluated for the first time the specific role of the CB2R in food addiction by using a well-validated operant mouse model of long-term training to obtain highly palatable food. We have compared in this model the behavioral responses of wild-type mice, mutant mice constitutively lacking CB2R, and transgenic mice overexpressing CB2R. The lack of CB2R constitutes a protective factor for the development of food addiction and the impulsive and depressive-like behavior associated. In contrast, the overexpression of CB2R induces a vulnerable phenotype toward food addiction after long-term exposure to highly palatable chocolate pellets. Relevant transcriptomic changes were associated to resilience and vulnerability to food addiction depending on the genotype, which provides a mechanistic explanation for these behavioral changes. Therefore, CB2R may constitute a potential therapeutic target for the loss of eating control and the comorbid emotional effects associated to food addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to RM; the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to RM; the “ICREA-Acadèmia” (2020) to RM; the “European Commission-DG Research” (PainFact, H2020-SC1–2019-2-RTD-848099, QSPain Relief, H2020-SC1–2019-2-RTD-848068) to RM; the Spanish”la Caixa” Foundation under the project code LCF/PR/HR22/52420017 to R.M., the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM; the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to RM; PNSD- 2019I006, to EMG; Ministerio de Ciencia e Innovación (ERA-NET) PCI2021–122073-2A to EMG; and “Instituto de Salud Carlos III”, Spanish “Ministerio de Ciencia e Innovación” (RD21/0009/0008, “Red de Investigación en Atención Primaria de Adicciones”) to JM.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulenaite, Solveiga
  • García Blanco, Alejandra
  • Mayneris Perxachs, Jordi
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Objective: Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction. Design: We used the Yale Food Addiction Scale (YFAS) 2.0 criteria to classify extreme food addiction in mouse and human subpopulations to identify gut microbiota signatures associated with vulnerability to this disorder. Results: Both animal and human cohorts showed important similarities in the gut microbiota signatures linked to food addiction. The signatures suggested possible non-beneficial effects of bacteria belonging to the Proteobacteria phylum and potential protective effects of Actinobacteria against the development of food addiction in both cohorts of humans and mice. A decreased relative abundance of the species Blautia wexlerae was observed in addicted humans and of Blautia genus in addicted mice. Administration of the non-digestible carbohydrates, lactulose and rhamnose, known to favour Blautia growth, led to increased relative abundance of Blautia in mice faeces in parallel with dramatic improvements in food addiction. A similar improvement was revealed after oral administration of Blautia wexlerae as a beneficial microbe. Conclusion: By understanding the crosstalk between this behavioural alteration and gut microbiota, these findings constitute a step forward to future treatments for food addiction and related eating disorders., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish 'Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)' (PID2020- 120029GB-I00/MICIU/AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), 'La Marató de TV3' #20221830, ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to EM-G. Spanish-MINECO (#SAF2017-84060-R-AEI/FEDER-UE) to LD-R, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100, #PID2021-127776OB-I00), ‘AGAUR-Generalitat de Catalunya’ (#2017-SGR-738, #2021-SGR-01093) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT-K-718-03-0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), 'La Marató de TV3' #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB-I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the 'CERCA Programme/Generalitat de Catalunya'.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Contribution of CD4+ cells in the emotional alterations induced by endometriosis in mice

  • Escudero Lara, Alejandra, 1992-
  • Cabañero Ferri, David
  • Maldonado, Rafael, 1961-
Endometriosis is a disease defined by the presence of endometrial tissue in extrauterine locations. This chronic condition is frequently associated with pain and emotional disorders and has been related with altered immune function. However, the specific involvement of immune cells in pain and behavioral symptoms of endometriosis has not been yet elucidated. Here, we implement a mouse model of non-surgical endometriosis in which immunocompetent mice develop abdomino-pelvic hypersensitivity, cognitive deficits, anxiety and depressive-like behaviors. This behavioral phenotype correlates with expression of inflammatory markers in the brain, including the immune cell marker CD4. Depletion of CD4 + cells decreases the anxiety-like behavior of mice subjected to the endometriosis model, whereas abdomino-pelvic hypersensitivity, depressive-like behavior and cognitive deficits remain unaltered. The present data reveal the involvement of the immune response characterized by CD4 + white blood cells in the anxiety-like behavior induced by endometriosis in mice. This model, which recapitulates the symptoms of human endometriosis, may be a useful tool to study the immune mechanisms involved in pain and behavioral alterations associated to endometriosis., “Instituto de Salud Carlos III,” “Redes temáticas de investigación cooperativa en salud—Red de trastornos adictivos” (#RD16/0017/0020), “Ministerio de Ciencia e Innovación” MICIN y “Agencia Estatal de Investigación” AEI (#PID2020-120029GBI00/MICIN/AEI/10.13039/50110001 1033), and “Generalitat de Catalunya- Agència de Gestió d’Ajuts Universitaris i de Recerca-AGAUR” (#2017-SGR-669 and #ICREA Acadèmia2020) to RM are acknowledged.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Auricular transcutaneous vagus nerve stimulation acutely modulates brain connectivity in mice.

  • Brambilla Pisoni, Cecilia, 1993-
  • Muñoz Moreno, Emma
  • Gallego-Amaro, Ianire
  • Maldonado, Rafael, 1961-
  • Ivorra Cano, Antoni, 1974-
  • Soria Rodríguez, Guadalupe
  • Ozaita Mintegui, Andrés, 1969-
Brain electrical stimulation techniques take advantage of the intrinsic plasticity of the nervous system, opening a wide range of therapeutic applications. Vagus nerve stimulation (VNS) is an approved adjuvant for drug-resistant epilepsy and depression. Its non-invasive form, auricular transcutaneous VNS (atVNS), is under investigation for applications, including cognitive improvement. We aimed to study the effects of atVNS on brain connectivity, under conditions that improved memory persistence in CD-1 male mice. Acute atVNS in the cymba conchae of the left ear was performed using a standard stimulation protocol under light isoflurane anesthesia, immediately or 3 h after the training/familiarization phase of the novel object-recognition memory test (NORT). Another cohort of mice was used for bilateral c-Fos analysis after atVNS administration. Spearman correlation of c-Fos density between each pair of the thirty brain regions analyzed allowed obtaining the network of significant functional connections in stimulated and non-stimulated control brains. NORT performance was enhanced when atVNS was delivered just after, but not 3 h after, the familiarization phase of the task. No alterations in c-Fos density were associated with electrostimulation, but a significant effect of atVNS was observed on c-Fos-based functional connectivity. atVNS induced a clear reorganization of the network, increasing the inter-hemisphere connections and the connectivity of locus coeruleus. Our results provide new insights into the effects of atVNS on memory performance and brain connectivity extending our knowledge of the biological mechanisms of bioelectronics in medicine., The project that gave rise to these results received the support of a fellowship from la Caixa Foundation (ID 100010434). The fellowship code is LCF/BQ/IN18/11660012 (CB-P). This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Slodowska-Curie grant agreement No. 713673. This work was supported by the Ministerio de Economía, Innovación y Competitividad (MINECO) (#RTI2018-099282-B-I00 to AO and PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033 to RM); the Instituto de Salud Carlos III (#RD16/0017/0020 to RM and PI18/00893 cofunded by ERDF A way to make Europe to GS); the Generalitat de Catalunya (2017SGR-669 to RM); the ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to AO, AI, and RM; Grant Unidad de Excelencia María de Maeztu, funded by the MINECO (#MDM-2014-0370); and PLAN E (Plan Español para el Estímulo de la Economía y el Empleo). FEDER funding is also acknowledged.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Dysregulated eating behaviour and microbiota-based interventions targeting eating disorders and food addiction

  • Samulenaite, Solveiga
  • Rodriguez Parkitna, Jan
  • Baltriukienė, Daiva
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Burokas, Aurelijus, 1982-
The consumption of highly processed, hyperpalatable food in Western societies increases the risk of developing obesity and compulsive eating behaviors, which include food addiction (FA) and eating disorders (EDs), such as bulimia nervosa (BN) and binge eating disorder (BED). These behaviors can lead to a range of health consequences, including cardiovascular and metabolic diseases, cognitive impairments, and mental health disorders, among others. Given the evidence suggesting the involvement of the gut microbiota in regulating eating behavior, in recent years, scientists have sought to identify microbiota signatures associated with EDs and FAs. Multiple pro- and prebiotics, as well as other microbiota-based therapeutic interventions, have been suggested as preventive or treatment strategies for FA and EDs. To provide a comprehensive overview, this review is structured into two main sections. The first section describes compulsive eating behaviors, namely, BN, BED, and FA, recognizing their similarities and differences, and highlighting the importance of the proper distinction for the selection of targeted and effective treatment approaches. The second section provides an extensive summary of the recent research years behind the search for microbiota signatures and potential microbiota-based therapeutic interventions for managing EDs and FA in both humans and animal models., This work was supported by the European Commission under the HORIZON Coordination and Support Actions Grant Pan-European Network for Neuroscience Research Infrastructure and Strengthening of Support capacities (PANERIS), Grant Agreement No. 101160180. And the Research Council of Lithuania (LMTLT) and ERA-NET NEURON Joint Transnational Call (S-NEURON-25-1) for the project “EMPATHY: Early Metabolic Programming Affects Hypothalamus Yielding Eating Disorders.” And the Spanish “Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (AEI)” (PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019 and PDI2023-1511680B-C21), the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (#RD12/0028/0023), the “Generalitat de Catalunya, AGAUR” (#2020 SGR-669), “ICRalterations, with microbiota EA-Acadèmia” (#2025) and the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad,” “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2017I068, #PNSD-2019I006, #PNSD-2023I040) to R.M., "la Caixa Health” LCR/PR/HR22/5240017 to R.M. and E.M-G., and Spanish “Ministerio de Ciencia e Innovación” (ERA-NET) PCI2021-122073-2A to E.M-G.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model

  • Cajiao-Manrique, María Del Mar
  • Casadó-Anguera, Verònica
  • García Blanco, Alejandra
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Background: Cannabis addiction is a chronically relapsing disorder lacking effective treatment. Regular cannabis consumption typically begins during adolescence, and this early cannabinoid exposure may increase the risk for drug addiction in adulthood. Objective: This study investigates the development of cannabis addiction-like behavior in adult mice after adolescent exposure to the main psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC). Methods: Adolescent male mice were exposed to 5 mg/kg of THC from postnatal days 37 to 57. Operant self-administration sessions of WIN 55,212-2 (12.5 μg/kg/infusion) were conducted for 10 days. Mice were tested for three addiction-like criteria (persistence of response, motivation, and compulsivity), two parameters related to craving (resistance to extinction and drug-seeking behavior), and two phenotypic vulnerability traits related to substance use disorders (impulsivity and reward sensitivity). Additionally, qPCR assays were performed to detect differentially expressed genes in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), dorsal striatum, and hippocampus (HPC) of "addicted" and "non-addicted" mice. Results: Adolescent THC exposure did not modify WIN 55,212-2 reinforcement nor the development of cannabis addiction-like behavior. Inversely, THC pre-exposed mice displayed impulsive-like behavior in adulthood, which was more pronounced in mice that developed the addiction-like criteria. Moreover, downregulated drd2 and adora2a gene expression in NAc and HPC was revealed in THC pre-exposed mice, as well as a downregulation of drd2 expression in mPFC of vehicle pre-treated mice that developed addiction-like behaviors. Discussion: These findings suggest that adolescent THC exposure may promote impulsivity-like behavior in adulthood, associated with downregulated drd2 and adora2a expression in NAc and HPC., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, R D21/0009/0019) to RM, the “Generalitat de Catalunya, AGAUR” (2017 SGR-669) to RM, the “ICREA-Acadèmia” (2020) to RM, the “European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099 and QSPain Relief, H2020-SC1-2019-2-RTD-848068) to RM, the Spanish “La Caixa” Foundation under the project code LCF/PR/HR22/52420017 to RM, the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM, the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD-2021I076 to RM and PNSD-2019I006 to EM-G), and Ministerio de Ciencia e Innovación (ERA-NET NEURON) PCI2021-122073-2A to EM-G. MC-M acknowledged the Generalitat de Catalunya and the AGAUR for a “FI-SDUR” scholarship (EMC/3345/2020). AG-B acknowledged the Generalitat de Catalunya and the AGAUR for the “FI” scholarship (FI_B00337_2020). VC-A acknowledged the Spanish MCIN/AEI/10.13039/501100011033 for a “Juan de la Cierva” fellowship (FJC2019-041020-I).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Microbiota alterations in proline metabolism impact depression

  • Mayneris Perxachs, Jordi
  • Martin, Miquel
  • Burokas, Aurelijus, 1982-
  • Escrichs, Anira
  • Deco, Gustavo
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with low treatment efficacy. However, the field is dominated by underpowered studies focusing on major depression not addressing microbiome functionality, compositional nature, or confounding factors. We applied a multi-omics approach combining pre-clinical models with three human cohorts including patients with mild depression. Microbial functions and metabolites converging onto glutamate/GABA metabolism, particularly proline, were linked to depression. High proline consumption was the dietary factor with the strongest impact on depression. Whole-brain dynamics revealed rich club network disruptions associated with depression and circulating proline. Proline supplementation in mice exacerbated depression along with microbial translocation. Human microbiota transplantation induced an emotionally impaired phenotype in mice and alterations in GABA-, proline-, and extracellular matrix-related prefrontal cortex genes. RNAi-mediated knockdown of proline and GABA transporters in Drosophila and mono-association with L. plantarum, a high GABA producer, conferred protection against depression-like states. Targeting the microbiome and dietary proline may open new windows for efficient depression treatment., This work was partially supported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, and PI21/01361 to J.M.F.-R. and PI20/01090 (co-funded by the European Regional Development Fund. “A way to make Europe”) to J.M.-P.; the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R.; the Spanish Ministry of Science, Innovation and Universities (PID2019-105969GB-I00); Generalitat Valenciana (Prometeo/2018/133), Spain; and Fondo Europeo de Desarrollo Regional (FEDER) funds to A.M. This work was also supported by the European Commission (FP7, NeuroPain #2013-602891); the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020) to R.M.; the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) to R.M.; Ministry of Science and Innovation and State Research Agency (#PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033) to R.M.; the European Regional Development Fund (project no. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra program (POCTEFA, 2014–2020). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00) and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [SLT002/16/00250]) to R.P. M.A.-R. is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). J.M.-P. is funded by a Miguel Servet contract (CP18/00009) from the Instituto de Salud Carlos III. J.S. is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. M.J. is a professor under “Serra Hunter” program (Generalitat de Catalunya). The graphical abstract was created with BioRender.com. We would like to thank Martijn Eidhof for his help in building the stress treatment machine for Drosophila.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Targeting dysregulated CB1 receptors in a down syndrome mouse model improves neurological outcomes

  • Vázquez-Oliver, Anna
  • Pérez-García, Silvia
  • Romero-Pérez, Rafael
  • Pizarro Lozano, Ma. Nieves
  • Galarraga-Shinin, Diana
  • Molina-Porcel, Laura
  • Torre Fornell, Rafael de la
  • Maldonado, Rafael, 1961-
  • Ozaita Mintegui, Andrés, 1969-
INTRODUCTION: Down syndrome (DS) is the most common genetic cause of intellectual disability, affecting cognitive function and increasing the risk of early-onset Alzheimer's disease (AD). The endocannabinoid system may serve as a therapeutic target for cognitive deficits by inhibiting cannabinoid type-1 receptor (CB1R) function. METHODS: CB1R expression was analyzed in the hippocampi of aged DS-associated AD (DSAD) individuals and middle-aged Ts65Dn mice. Long-term oral treatment with the CB1R antagonist rimonabant was used to assess its effects on memory and neuroinflammation in the Ts65Dn mouse model of DS. RESULTS: CB1R expression was significantly increased in both aged DSAD subjects (specifically in the dentate gyrus and CA2 posterior hippocampal subregions) and Ts65Dn mice. Long-term rimonabant treatment improved memory performance, normalized microglial morphology, and reduced plasma inflammatory markers in trisomic mice without preventing neuron decline. DISCUSSION: These findings suggest that sustained CB1R inhibition may enhance cognitive function by modulating neuroinflammation, highlighting its therapeutic potential for cognitive impairments in DS. Highlights: Cannabinoid type-1 receptor (CB1R) expression is increased in the posterior hippocampus of aged Down syndrome (DS) subjects and Ts65Dn mice. Long-term rimonabant treatment enhances memory in middle-aged Ts65Dn mice. CB1R inhibition shifts neuroinflammatory features in Ts65Dn mice. CB1R inhibition does not halt noradrenergic/cholinergic neurodegeneration in Ts65Dn. CB1R inhibition presents potential for memory improvement in DS-related deficits., Ministerio de Ciencia, Innovación y Universidades, Grant/Award Numbers:RTI2018-099282-B-I00, PID2021-123482OB-I00-/MICIN/AEI/10.13039/501100011033/FEDER,PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033; Fondation Jérôme Lejeune, Grant/Award Numbers:1896_GRT-2019B, #2416_GRT-2024B; Bright Focus foundation, Grant/Award Number:CA2018010; Ministerio de Sanidad, Servicios Sociales e Igualdad, Grant/Award Number:RD16/0017/0020; Departament de Recerca i Universitats, Generalitat de Catalunya,Grant/Award Number: 2017SGR-669 Departament d'Economia i Coneixement, Generalitat de Catalunya, Grant/Award Number: 2017SGR-138; Institució Catalana de Recerca i Estudis Avançats, ICREA-Acadèmia2021
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A male mouse model of WIN 55,212-2 self-administration to study cannabinoid addiction

  • Cajiao-Manrique, María del Mar
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Martín-García, Elena|||0000-0002-4487-3028
We have established for the first time a mouse model of cannabinoid addiction using WIN 55,212-2 intravenous self-administration (0.0125 mg/kg/infusion) in C57Bl/6J mice. This model allows to evaluate the addiction criteria by grouping them into 1) persistence of response during a period of non-availability of the drug, 2) motivation for WIN 55,212-2 with a progressive ratio, and 3) compulsivity when the reward is associated with a punishment such as an electric foot-shock, in agreement with the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5). This model also allows to measure two parameters that have been related with the DSM-5 diagnostic criteria of craving, resistance to extinction and reinstatement, and two phenotypic traits suggested as predisposing factors, impulsivity and sensitivity to reward. We found that 35.6% of mice developed the criteria of cannabinoid addiction, allowing to differentiate between resilient and vulnerable mice. Therefore, we have established a novel and reliable model to study the neurobiological correlates underlying the resilience or vulnerability to develop cannabinoid addiction. This model included the chemogenetic inhibition of neuronal activity in the medial prefrontal cortex to the nucleus accumbens pathway to assess the neurobiological substrate of cannabinoid addiction. This model will shed light on the neurobiological substrate underlying cannabinoid addiction.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model

  • Cajiao-Manrique, María del Mar
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • García-Blanco, Alejandra
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Martín-García, Elena|||0000-0002-4487-3028
Cannabis addiction is a chronically relapsing disorder lacking effective treatment. Regular cannabis consumption typically begins during adolescence, and this early cannabinoid exposure may increase the risk for drug addiction in adulthood. This study investigates the development of cannabis addiction-like behavior in adult mice after adolescent exposure to the main psychoactive component of cannabis, Δ 9 -tetrahydrocannabinol (THC). Adolescent male mice were exposed to 5 mg/kg of THC from postnatal days 37 to 57. Operant self-administration sessions of WIN 55,212-2 (12.5 μg/kg/infusion) were conducted for 10 days. Mice were tested for three addiction-like criteria (persistence of response, motivation, and compulsivity), two parameters related to craving (resistance to extinction and drug-seeking behavior), and two phenotypic vulnerability traits related to substance use disorders (impulsivity and reward sensitivity). Additionally, qPCR assays were performed to detect differentially expressed genes in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), dorsal striatum, and hippocampus (HPC) of "addicted" and "non-addicted" mice. Adolescent THC exposure did not modify WIN 55,212-2 reinforcement nor the development of cannabis addiction-like behavior. Inversely, THC pre-exposed mice displayed impulsive-like behavior in adulthood, which was more pronounced in mice that developed the addiction-like criteria. Moreover, downregulated drd2 and adora2a gene expression in NAc and HPC was revealed in THC pre-exposed mice, as well as a downregulation of drd2 expression in mPFC of vehicle pre-treated mice that developed addiction-like behaviors. These findings suggest that adolescent THC exposure may promote impulsivity-like behavior in adulthood, associated with downregulated drd2 and adora2a expression in NAc and HPC.